| Spring 2022 Statistics | |||
| Applications Received: 161 (142 reviewed by RAP; 19 reviewed independently) | |||
| Grant Mechanism | Applications Reviewed | Applications Awarded | % Awarded |
| CAPS-HIV Innovative Grants | 1 | 1 | 100% |
| Core Award for Research and Development (CARD) | 3 | 2 | 67% |
| Core Operational Improvement Awards (COIA) | 1 | 1 | 100% |
| Family Support Award | 5 | 4 | 80% |
| Gilead HIV Cure Mentored Scientist Award | 0 | 0 | 0% |
| Global Cancer Pilot Award | 1 | 1 | 100% |
| Hardship Awards | 3 | 1 | 33% |
| Independence Support Award | 0 | 0 | 0% |
| Informing Tobacco Product Regulation | 2 | 0 | 0% |
| International Mentored Scientist Award Program in HIV/AIDS | 3 | 2 | 67% |
| Mentored Scientist Award in Tuberculosis | 4 | 2 | 50% |
| Mentored Scientist Award Program in HIV/AIDS | 9 | 6 | 67% |
| Pilot Award for Investigators New to HIV | 0 | 0 | 0% |
| Pilot Award for Pancreas Cancer | 0 | 0 | 0% |
| Pilot Award for Prevention and Treatment of Opioid Use Disorders | 2 | 0 | 0% |
| Pilot Award for Utility of Biomarkers in Substance Abuse Research | 0 | 0 | 0% |
| Pilot Award in Precision Imaging of Cancer and Therapy | 5 | 3 | 60% |
| Pilot for Early Career Investigators | 36 | 12 | 33% |
| Pilot for Established Investigators | 46 | 17 | 37% |
| Re-entry | 1 | 0 | 0% |
| Shared Technology Awards | 4 | 1 | 25% |
| Team Science Grant | 8 | 1 | 13% |
| Under-represented Faculty in Clinical and Translational Research Awards | 8 | 4 | 50% |
| Total | 142 | 58 | |
| Overall Funding Rate | 41% | ||
| Submission Version | |||
| New Submission | 117 | ||
| 1st Resubmission | 25 | ||
| Total | 142 | ||